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Edited by Christian GriesingerAbstract UV ﬁlters protect the human lens and retina from
UV light-induced damage. Here, we report the identiﬁcation of
a new UV ﬁlter, cysteine-L-3-hydroxykynurenine O-b-D-gluco-
side, which is present in older normal human lenses. Its structure
was conﬁrmed by independent synthesis. It is likely this novel UV
ﬁlter is formed in the lens by nucleophilic attack of cysteine on the
unsaturated ketone derived from deamination of 3-hydroxykynu-
renine O-b-D-glucoside. Quantitation studies revealed consider-
able variation in normal lens levels that may be traced to the
marked instability of the cysteine adduct. The novel UV ﬁlter
was not detected in advanced nuclear cataract lenses.
Crown Copyright  2006 Published by Elsevier B.V. on behalf
of the Federation of European Biochemical Societies. All rights
reserved.
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Themajor UV ﬁlters found in human lenses are 3-hydroxyky-
nurenine O-b-D-glucoside (3OHKG), 4-(2-amino-3-hydroxy-
phenyl)-4-oxobutanoic acid O-b-D-glucoside (AHBG),
3-hydroxykynurenine (3OHKyn) and kynurenine (Kyn) [1–5].
These UV ﬁlters function to protect the lens and retina from
UV damage by absorbing light in the 295–400 nm range [6,7].
Work in our laboratory has shown these UV ﬁlters are unstable
at physiological pH and undergo a range of reactions, including
deamination to form a,b-unsaturated ketones [8], which are cap-Abbreviations: AHBG, 4-(2-amino-3-hydroxyphenyl)-4-oxobutanoic
acidO-b-D-glucoside; AHBdiG, 4-(2-amino-3-hydroxyphenyl)-4-oxob-
utanoic acid O-b-D-diglucoside; Cys-3OHKG, cysteine-3-hydroxyky-
nurenineO-b-D-glucoside; ESI, electrospray ionisation; GSH-3OHKG,
glutathione-3-hydroxykynurenine O-b-D-glucoside; Kyn, kynurenine;
MS, mass spectrometry; MS/MS, tandem MS; 3OHKG, 3-hydroxyky-
nurenine O-b-D-glucoside; 3OHKyn, 3-hydroxykynurenine; RP-HPL-
C, reversed phase-high performance liquid chromatography; TFA,
triﬂuoroacetic acid
*Corresponding author. Fax: +61 2 4221 4287.
E-mail address: rjwt@uow.edu.au (R.J.W. Truscott).
1 P.G.H. and J.M. contributed equally to this manuscript.
0014-5793/$32.00 CrownCopyright 2006 Published byElsevier B.V. on behal
doi:10.1016/j.febslet.2006.08.026able of reacting with nucleophilic amino acids including Cys,
His and Lys [9,10]. The binding of UV ﬁlters, and other reac-
tive small molecules [11–14] to crystallin proteins results in
the normal human lens becoming more coloured with age
[8,15–19].
The anti-oxidant glutathione (GSH) is present in the lens in
high concentrations (6 mM) [20], however, like the UV ﬁlters,
its concentration has been shown to decrease with age [20,21].
GSH reacts with deaminated 3OHKG to form glutathione-3-
hydroxykynurenine O-b-D-glucoside (GSH-3OHKG), a novel
UV ﬁlter that, in contrast to other UV ﬁlters, increases in
concentration with age [22]. In the lens, reaction of the a,b-
unsaturated ketones with GSH may act to protect the crystal-
lins from modiﬁcation [23].
The decreasing concentration of UV ﬁlters may play an
important role in the development of nuclear cataract [24]
and as such, it is important to understand the changes that
occur in normal and cataractous lenses. In this paper, we
identify and quantify cysteine-3-hydroxykynurenine O-b-D-
glucoside (Cys-3OHKG) in normal human lenses. It is likely
that this novel human metabolite is formed in the lens by reac-
tion of free cysteine with deaminated 3OHKG.2. Materials and methods
2.1. Materials
All organic solvents and acids were of HPLC grade (Ajax, Auburn,
NSW, Australia); triﬂuoroacetic acid (TFA) (>99%) and L-cysteine
(free base) were from Sigma–Aldrich; chelex resin (100–200 mesh)
was from BioRad. Milli-Q water (puriﬁed to 18.2 MX cm2) was
used in the preparation of all solutions. Dulbelco’s phosphate-buﬀered
saline (PBS), without calcium and magnesium, consisted of KCl
2.7 mM, KH2PO4 1.4 mM, NaCl 137 mM, Na2HPO4 7.68 mM, pH
7.0 [25]. The pre-washed chelex resin was added to the PBS buﬀer
(2 g/l) and left for 24 h prior to use. TLC plates were of normal phase
60 F254 (Merck, Germany) using a mobile phase of butanol/acetic acid/
water (12:3:5, v/v/v). TLC plates were visualised under UV light (254
and 365 nm) and sprayed with ninhydrin.2.2. Nuclear magnetic resonance (NMR) spectroscopy
1H, 13C, DEPT (45, 90, 135), COSY (1H–1H correlation spectro-
scopy), HSQC (1H–13C heteronuclear single quantum correlation)
and HMBC (1H–13C heteronuclear multiple bond correlation) NMR
experiments were acquired on a Bruker Avance 400 spectrometer
(1H, 400 MHz; 13C, 100 MHz) at 25 C. NMR spectra were run in
D2O and referenced to residual HDO. Resonances are quoted in
ppm and coupling constants (J) are given in Hz.f of the Federation of European Biochemical Societies. All rights reserved.
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Peaks collected from RP-HPLC were lyophilised, resuspended in
50% (v/v) acetonitrile, 0.5% (v/v) formic acid and analysed by electro-
spray ionisation MS in positive ion mode using a Micromass Q-TOF2
equipped with a nanospray source. MS settings were as follows; cone
voltage 25 V, LM/HM 12/12, MCP 2300 V, mass range 50–600 m/z.
For tandem MS (MS/MS) analysis, ions were subjected to a range of
collisions energy settings (typically between 10 and 25 eV). High reso-
lution mass spectrometry was performed on a Q-TOF Ultima with
lock spray. Leucine-encephalin (555.2692 Da) was used as the refer-
ence compound.
2.4. Fluorescence and UV–visible absorbance spectrometric
measurements
UV–visible absorbance spectra were obtained using a Varian DMS
90 UV–visible spectrometer and Plastibrand 0.5 ml disposable cuv-
ettes (Germany). Fluorescence spectra were recorded on a Perkin–
Elmer LS55 Luminescence spectrometer in two- and three-dimensional
scan mode using Perkin–Elmer 10 · 10 mm Quartz SUPRASIL
3.5 ml ﬂuorescence cells. PBS was used as solvent for all measurements
with Cys-3OHKG at a concentration of 5.5 mg/ml.
2.5. Cys-3OHKG synthesis
3OHKG [26] (20 mg, 0.064 mmoL) was dissolved in oxygen free
Na2CO3–NaHCO3 buﬀer (20 ml, 25 mM, pH 9.2). Free base L-cysteine
(90 mg, 0.74 mmoL) was added and the pH was re-adjusted to pH 9.2
by the dropwise addition of 1 M NaOH. The light yellow solution was
bubbled with argon for 20 min, sealed with paraﬁlm and incubated in
the dark at 37 C with shaking. The progress of the reaction was mon-
itored by TLC (RfCys-3OHKG 0.26). After 24 and 48 h another portion
of cysteine (90 mg, 0.74 mmoL) was added to the reaction mixture and
the pH was readjusted to 9.2. After 72 h the light yellow reaction mix-
ture was acidiﬁed to pH 6.5 by dropwise addition of 1 M acetic acid
and lyophilised. Puriﬁcation by preparative reversed phase-high per-
formance liquid chromatography (RP-HPLC), as described below,
aﬀorded Cys-3OHKG (9 mg, 35.5%) as a light yellow solid.
Found: M, 490.1274 Da. Calculated for C19H26N2O11S: M,
490.1257 Da; dH 7.55 (1H, d, J, 8.3, H-6), 7.24 (1H, d, J 7.9, H-4),
6.71 (1H, dd, J 8.1, 8.3, H-5), 4.94 (1H, dd, J 1.5, 7.4, H-10), 3.93
(1H, m, H-12), 3.75 (1H, m, H-9), 3.60 (0.5H, m, H-8), 3.57
(0.5H, m, H-8), 3.49 (0.5H, m, H-8), 3.45 (0.5H, m, H-8), 3.82
(1H, dd, J 1.1, 12.4, H-6 0), 3.67 (1H, dd, J 5.26, 12.44, H-60), 3.53
(1H, m, H-30), 3.52 (1H, m, H-2 0), 3.48 (1H, m, H-5 0), 3.42 (1H, m,
H-4 0), 3.32 (0.5H, dd, J 4.1, 14.7, H-11), 3.25 (0.5H, dd, J 4.3,
14.8, H-11), 3.18 (0.5H, m, H-11), 3.08 (0.5H, m, H-11); dC
201.6 (CO-7), 201.4 (CO-7), 184.0 (CO-10), 172.5 (CO-13), 145.2 (C-
3), 141.6 (C-2), 126.3 (C-6), 121.0 (C-4), 119.0 (C-1), 116.4 (C-5),
101.9 (C-1 0), 76.5 (C-50), 75.9 (C-2 0), 73.2 (C-3 0), 69.73 (C-4 0), 60.8
(C-6 0), 54.3 (C-12), 45.5 (C-9), 43.3 (C-9), 42.8 (C-8), 42.1 (C-8), 33.2
(C-11), 32.2 (C-11); electrospray ionisation (ESI)-MS/MS of m/z
491.1 (MH+, 52%), 473.1 (100%), 370.1 (24%), 329.0 (13%), 311.1
(71%), 272.2 (11%), 208.2 (32%), 202.1 (63%), 110.0 (27%).
2.6. Stability studies
Cys-3OHKG was dissolved in chelex treated PBS (pH 7.0) that was
degassed with argon for 20 min to give a ﬁnal concentration of
0.20 mM. 3 · 4 ml Cys-3OHKG solutions were sealed under argon
and incubated in the dark at 37 C with minimum shaking. Single ali-
quots (110 ll) were taken from each solution at 0, 1, 2, 3, 4, 6, 8, 11, 23,
32, 46, 57, 94, 120, 134, 168, 192, 216 and 240 h and analysed by RP-
HPLC.
2.7. Puriﬁcation of synthetic Cys-3OHKG
Reversed phased-high performance liquid chromatography (RP-
HPLC) was performed on a Shimadzu HPLC equipped with LC-
10ADvp pumps, a SIL-10Avp autoinjector, DGU-12A degasser and
SPD-M10Avp diode array detector. Standard curves and stability sam-
ple analyses were performed on a Phenomenex (Luna, 100 A˚, 5 lm,
250 mm · 4.6 mm, C18) column with the following mobile phase sys-
tem: buﬀer A (water/0.05% TFA, v/v) and buﬀer B (80% acetonitrile/
0.05% TFA, v/v). The ﬂow rate of 1 ml/min was kept constant with
the mobile phase gradient: 5% buﬀer B (4 min), 5–80% buﬀer B
(12 min), hold at 80% buﬀer B (3 min), 80–5% buﬀer B (3 min) and
hold at 5% buﬀer B (8 min). Detection was at 254 nm and 360 nm. Pre-parative separations were performed on the same instrument with the
same mobile phase system as for the analytical separations using a Phe-
nomenex (Luna, 100 A˚, 10 lm, 250 mm · 15 mm, C18) column. The
ﬂow rate of 7 ml/min was kept constant with the mobile phase gradi-
ent: 5% buﬀer B (10 min), 5–70% buﬀer B (20 min), hold at 70% buﬀer
B (5 min), 70–5% buﬀer B (5 min) and hold at 5% buﬀer B (10 min).
2.8. UV ﬁlter extraction and RP-HPLC
Normal human lenses were obtained from the Sydney Eye Bank,
with ethical approval from the University of Wollongong Human Eth-
ics Committee (HE99/001). Cataractous lenses were obtained from
K.T. Seth Eye Hospital, Rajkot, Gujarat, India. UV ﬁlters were ex-
tracted from both nuclear and cortical lens sections as previously
described [27]. A total of 8 normal lenses were analysed, 2 each from
the 3rd, 5th, 7th and 9th decades. UV ﬁlters were also extracted from
a set of 10 dark cataract lenses (assigned as Types III–IV according to
the Pirie classiﬁcation system [28], average age 66.6 years) and pooled.
UV ﬁlters were additionally extracted from 15 individual cataract
lenses (assigned as Types I–IV, inclusive). In all cases, lens extracts
(individual and pooled) were lyophilised and resuspended in 100 ll
of 0.1% (v/v) TFA, water prior to RP-HPLC analysis. Standard curve
and lens separations were performed on a 250 mm · 4.6 mm 100 A˚
Varian Microsorb MV C18 column using an acetonitrile/H2O gradient
in 0.1% (v/v) TFA at a ﬂow rate of 0.5 ml/min. The percentage of buf-
fer B (0.08% (v/v) TFA, 80% [v/v] acetonitrile, water) in the gradient
was 0% buﬀer B (5 min), 0–50% buﬀer B (50 min), and 50–0% buﬀer
B (5 min). Eluant was monitored at 360 nm.3. Results
A typical elution proﬁle of UV ﬁlters extracted from a nor-
mal lens nucleus is shown in Fig. 1. An unknown compound
eluted as a doublet at 20% acetonitrile, 0.1% TFA. These
peaks (Peak 3, Fig. 1) were further analysed by MS and MS/
MS (Fig. 2A) with the identiﬁcation of a major molecular
ion at 491.13 [M+H]+, correlating to a mass of 490.13 Da.
The MS/MS data suggested the identity of the compound as
Cys-3OHKG. This preliminary identiﬁcation was from neutral
losses of 162 Da (glucose), 109.05 Da (ortho-amino-phenol of
3OHKyn), 98 Da (deaminated side chain of 3OHKG),
121 Da (cysteine) and 18 Da (water), as indicated. All major
ions observed in the spectra (Fig. 2A) can be accounted for
by loss of various combinations of these compounds. The
HPLC proﬁle for both nuclear and cortical extracts were
essentially identical (data not shown).
Cys-3OHKG was synthesised by incubating L-cysteine with
3OHKG at pH 9.2 and 37 C. It has been previously demon-
strated that the amino acid side chains of Kyn and 3OHKG
deaminate readily under basic conditions [19,22,29,30] and
that the a,b-unsaturated intermediate is readily attacked by
cysteine via a Michael addition [31]. The pH of 9.2 was also
beneﬁcial in forming a higher concentration of thiolate anions,
which is a stronger nucleophile than the thiol [31]. Due to
rapid cysteine oxidation, it was necessary to add cysteine every
24 h to ensure a good yield of Cys-3OHKG. The puriﬁed
material eluted as a diastereoisomeric doublet on RP-HPLC,
with the same retention time as the compound puriﬁed from
human lenses (data not shown). The MS/MS spectra were
identical (Fig. 2B), clearly indicating the identity of the
unknown as Cys-3OHKG. The structure of Cys-3OHKG is
shown in Fig. 1 inset.
Conﬁrmation of the structure of synthetic Cys-3OHKG was
achieved by one-dimensional and two-dimensional NMR. 1H
NMR revealed three aromatic protons as well as protons from
the glucose moiety consistent with those present in synthetic
Fig. 1. RP-HPLC proﬁle of UV ﬁlter extract from a normal lens nucleus (88 years old). The peaks are labelled 1–6 with the identiﬁcations
as indicated in the ﬁgure. 3OHKG, 3-hydroxykynurenine O-b-D-glucoside; Kyn, kynurenine; Cys-3OHKG, cysteine-3-hydroxykynurenine
O-b-D-glucoside; GSH-3OHKG, glutathione-3-hydroxykynurenine O-b-D-glucoside; AHBG, 4-(2-amino-3-hydroxyphenyl)-4-oxobutanoic acid
O-b-D-glucoside; AHBdiG, 4-(2-amino-3-hydroxyphenyl)-4-oxobutanoic acid O-b-D-diglucoside. Inset: structure of Cys-3OHKG.
Fig. 2. ESI-MS/MS spectra. ESI-MS/MS of the unknown compound (A) Sample and authentic Cys-3OHKG (B) Std in positive ion mode. Mass
diﬀerences between major ions are indicated in Daltons (Da).
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moiety, assigned by the combination of DEPT (90 and 45)
and HSQC. Chemical shifts at d 3.60 and 3.57 ppm were
assigned to the methylene protons at C-8 and at d 3.75 ppm
for the methine proton at C-9. The chemical shifts for the cys-
teine-methylene and methine protons were consistent with the
literature [19].
A UV–visible absorbance spectrum of Cys-3OHKG in PBS
at pH 7.0 showed major peaks at 262 nm and 365 nm. Cys-
3OHKG was also found to be ﬂuorescent under these condi-
tions; the UV ﬁlter showing a maximum excitation wavelength
at 337 nm and maximum emission at 438 nm (data not shown).
The stability of Cys-3OHKG was examined by incubating
the compound in PBS (pH 7.0) at 37 C. Cys-3OHKG was
found to rapidly decompose, with the amount of Cys-3OHKGdecreasing to 30% after only 2 h (Fig. 3). This is more rapid
than the decomposition of cysteine-kynurenine, which was
shown to degrade to 50% of the starting material after 24 h
[19]. The major products formed from the decomposition
of Cys-3OHKG, monitored by LC-MS, were deaminated
3OHKG and 3OHKG yellow [30]. After 240 h, 3OHKG
yellow, formed by cyclisation of deaminated 3OHKG [30],
represented approximately one third of the total deaminated
3OHKG.
UV ﬁlters from both the nuclear and cortical sections of indi-
vidual normal human lenses, ranging in age from 24 to 88, were
extracted and analysed by RP-HPLC. The amount of Cys-
3OHKG was determined from the area under the curve at
360 nm, by comparison with a standard curve constructed using
the synthetic compound. Cys-3OHKG was not detected in the
Fig. 3. Stability of Cys-3OHKG in chelex treated PBS at pH 7.0. The identity of deaminated 3OHKG was conﬁrmed by LC-MS. Results are
presented as average ± S.D.
Fig. 4. Quantitation of Cys-3OHKG in normal human lenses. Cys-
3OHKG was quantitated in the nucleus (black) and cortex (grey) of
normal human lenses.
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until the 7th decade (Fig. 4). The earlier detection of Cys-
3OHKG in the nucleus is consistent with the onset of the barrier
to diﬀusion that appears in human lenses at middle age [32].
This barrier between cortex and nucleus allows an increase in
the average time that small molecules spend in the lens nucleus
and thus more time for unstable molecules to decompose.
The concentration of nuclear Cys-3OHKG did not show any
clear correlation with age, whereas, cortical Cys-3OHKG does
appear to decrease with increasing age (Fig. 4). UV ﬁlters were
additionally extracted from 15 individual cataract, and a pool
of 10 dark cataract, lenses and analysed by RP-HPLC (data
not shown). A number of fractions were collected around the
known retention time of Cys-3OHKG and analysed by nano-
spray MS. There was no evidence of Cys-3OHKG in any of the
fractions collected from pooled or individual lenses.4. Discussion
In this paper, we report the identiﬁcation of a novel ﬂuoro-
phore, Cys-3OHKG, in normal human lenses. Its structurewas conﬁrmed by independent synthesis. It is very likely that
Cys-3OHKG is formed in the lens by addition of free cysteine
to the deamination product of 3OHKG in a manner analogous
to that of the formation of GSH-3OHKG [22]. A pronounced
increase in the covalent attachment of 3OHKG to lens proteins
has also been noted after middle age [8] and it is probable that
both cysteine and GSH compete with the nucleophilic residues
on lens proteins for addition to the a,b-unsaturated ketone
that is formed by spontaneous decomposition of 3OHKG. In
agreement with this, a plot of Cys-3OHKG versus GSH-
3OHKG in lenses showed a strong correlation (Fig. 5). Both
of the free thiols may therefore be viewed as potential scaveng-
ers of this reactive UV ﬁlter molecule and, as a result, they can
be considered to protect the long-lived proteins in the lens
nucleus from post-translational modiﬁcation.
Free cysteine is present in the cortex and nucleus of the
human lens and it is involved in thiolation of lens proteins
[33]. Dickerson and Lou [21] investigated the changes in free
cysteine concentration in normal human lenses as a function
of age. They found the concentration of cysteine decreased
markedly after 40 years of age. This may be related to a de-
crease in the rate of cysteine uptake which diminished by
70% when cultured newborn lenses were compared to old
(80–92 years) lenses [34]. Bova et al. found the concentration
of 3OHKG, and other major UV ﬁlters, decreased linearly
with age [20]. In our study, no clear age related correlation
was found for the concentration of Cys-3OHKG in the nu-
cleus, whereas, the concentration of cortical Cys-3OHKG
did show signs of decreasing relative to age (Fig. 4). Cys-
3OHKG was not detected in either the nucleus or cortex of
normal lenses prior to the 5th decade, the age at which cysteine
was found to decrease substantially [21]. Given the lack of a
clear relationship between the nuclear levels of Cys-3OHKG
and age, it appears the formation of Cys-3OHKG is not solely
inﬂuenced by the concentration of free cysteine or 3OHKG.
This is exempliﬁed by a plot of Cys-3OHKG versus 3OHKG,
where there is no correlation between the concentration of
these compounds in the nucleus or cortex of human lenses
(data not shown). By comparison, a plot of nuclear levels of
Cys-3OHKG versus GSH-3OHKG, shows a strong correla-
tion (R2 = 0.9105, Fig. 5) indicating any deaminated 3OHKG
Fig. 5. Plot of the nuclear concentration of Cys-3OHKG versus GSH-3OHKG in normal human lenses. The quantity of each compound was
determined by comparison to a standard curve. The R2 value is shown on the graph.
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tionship also holds for cortical levels of each compound, albeit
at a lower correlation (R2 = 0.7003). One factor that may ex-
plain a lack of a clear correlation between Cys-3OHKG levels
and age is the pronounced instability of Cys-3OHKG (Fig. 3).
Cys-3OHKG undergoes elimination more rapidly than GSH-
3OHKG. This may be related to greater accessibility by basic
species (e.g. hydroxyl ion) to the H-8 of Cys-3OHKG, facilitat-
ing elimination of cysteine, or due to the free a-amino group of
cysteine participating directly in deprotonation of H-8.
Like 3OHKG, Cys-3OHKG displays UV absorbance in the
300–400 nm band. This is relevant to its role as a lens UV ﬁlter
compound, since wavelengths of light longer than 300 nm are
transmitted by the cornea. Cys-3OHKG showed two absor-
bance maxima at 262 nm and 364 nm, very similar to GSH-
3OHKG (260 nm and 365 nm) and the major UV ﬁlter,
3OHKG (264 nm and 365 nm). Cys-3OHKG was also found
to be ﬂuorescent, with an excitation and emission spectrum
similar to that of 3OHKG [22].
RP-HPLC eluant was collected from individual and pooled
cataract lenses around the known retention time of Cys-
3OHKG and analysed by nanospray MS. No evidence of this
compound could be found for 15 individual, or a pooled ex-
tract of 10 cataract lenses. This suggests either the concentra-
tion of free cysteine or 3OHKG had decreased to a level
where Cys-3OHKG cannot form, or is formed in quantities
below the detection limit of the instrumentation used in this
study. This supposition is supported by recent work indicating
the level of 3OHKG decreased 5-fold in cataract lenses [24].
Additional reasons for the lack of Cys-3OHKG in cataract
lenses may be due to the instability of Cys-3OHKG at physio-
logical pH (Fig. 3), and the fact that it is very unlikely that free
cysteine is available in the nuclei of such lenses. The nucleus of
the advanced nuclear cataract lens is an oxidising environ-
ment in which GSH is very low or absent [35]. In conclusion,
an unstable ﬂuorescent and UV-absorbing molecule, Cys-
3OHKG, has been identiﬁed in normal older human lenses
but is absent from the lenses of patients with advanced nuclear
cataract.Acknowledgements: This work was supported by grants from the
National Institute of Health (RO1EY013570-03) and the National
Health and Medical Research Council (307615). R.J.W.T. is an
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